Startseite Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis

  • Sang Mee Hwang , Jeong-Ok Kim , Young-Mi Yoo , Sue Shin , Jin Q Kim , Myoung Hee Park und Eun Young Song
Veröffentlicht/Copyright: 4. Dezember 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Anti-cyclic citrullinated peptide (CCP) antibody is emerging as an important diagnostic marker for rheumatoid arthritis (RA). We evaluated the analytical and diagnostic performance of the ARCHITECT anti-CCP (Abbott Diagnostics), a new fully automated chemiluminescent microparticle immunoassay.

Methods: Serum samples from 69 patients with RA and 86 non-RA patients were used to evaluate the performance of the ARCHITECT anti-CCP assay, and the results were compared with those of EliA CCP (Phadia). The optimal cut-off value was calculated using receiver operating characteristic (ROC) curve analysis.

Results: Within-run and total imprecision (%CV) of the ARCHITECT anti-CCP were <6% and good linearity was observed over the claimed range. The areas under the ROC curves for the ARCHITECT anti-CCP and EliA CCP were 0.90 and 0.89, respectively. The sensitivity and specificity were 76.8% and 95.3% for the ARCHITECT anti-CCP and 78.3% and 95.3% for EliA CCP using the manufacturer's cut-off thresholds. Both assays showed sensitivity of 84.1% and specificity of 94.2% using the optimal cut-off values.

Conclusions: The analytical performance of the ARCHITECT anti-CCP was satisfactory and diagnostic performance was comparable to that of EliA CCP. The use of optimal cut-off thresholds can yield higher sensitivity with minimal loss of specificity.

Clin Chem Lab Med 2010;48:225–30.


Corresponding author: Eun Young Song, Department of Laboratory Medicine, College of Medicine, Seoul National University, 101 Daehang-ro, Jongno-gu, Seoul, Korea Phone: +82-2-2072-0197, Fax: +82-2-740-8872,

Received: 2009-8-7
Accepted: 2009-10-13
Published Online: 2009-12-04
Published in Print: 2010-02-01

©2010 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Review
  2. Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review
  3. Minireview
  4. Artificial intelligence for diagnostic purposes: principles, procedures and limitations
  5. General Clinical Chemistry and Laboratory Medicine
  6. Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005–2006
  7. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
  8. Plasma osteopontin concentrations in preeclampsia – is there an association with endothelial injury?
  9. Determination of globotriaosylceramide in plasma and urine by mass spectrometry
  10. Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis
  11. The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin
  12. Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements
  13. O-β-N-acetyl-D-glucosaminidase in erythrocytes of Italian air force acrobatic pilots
  14. Validation and Outcome Studies
  15. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis
  16. Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
  17. Reference Values and Biological Variations
  18. Applicability of common reference intervals for serum creatinine concentrations to the Croatian population
  19. Laboratory reference intervals during pregnancy, delivery and the early postpartum period
  20. Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory
  21. Definition of reference ranges for the platelet distribution width (PDW): a local need
  22. Cancer Diagnostics
  23. Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study
  24. Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma
  25. Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
  26. A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen
  27. Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access® prostate-specific antigen assays
  28. Infectious Diseases
  29. Use of flow cytometry (Sysmex® UF-100) to screen for positive urine cultures: in search for the ideal cut-off
  30. Letters to the Editor
  31. Improving laboratory efficiencies through significant time reduction in the preanalytical phase
  32. Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp.
Heruntergeladen am 10.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.046/html
Button zum nach oben scrollen